Immune checkpoint inhibitors increase the risk of hypothyroidism in patients with primary head and neck cancer compared to other cancers

被引：0
|
作者：
Alaber, Omar [1 ]
Chandar, Apoorva [1 ]
Mendiratta, Prateek [1 ]
Patel, Monaliben [1 ]
Hoimes, Chris [1 ]
Lavertu, Pierre [1 ]
Mangla, Ankit [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P710
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma
    Chang, Hui-Chin
    Gau, Shuo-Yan
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2025, 151 (02)
  • [22] Checkpoint inhibitors promising in lung, liver, head and neck and skin cancers
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (07) : 1566 - 1566
  • [23] Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer
    Chung, Chih-Hung
    Lin, Chun-Yu
    Chen, Chih-Yu
    Hsueh, Chun-Wei
    Chang, Yao-Wen
    Wang, Chen-Chi
    Chu, Pen-Yuan
    Tai, Shyh-Kuan
    Yang, Muh-Hwa
    ADVANCED SCIENCE, 2023, 10 (15)
  • [24] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Takuma Matoba
    Kiyoshi Minohara
    Daisuke Kawakita
    Gaku Takano
    Keisuke Oguri
    Akihiro Murashima
    Kazuyuki Nakai
    Sho Iwaki
    Hiroshi Tsuge
    Nobukazu Tanaka
    Sae Imaizumi
    Wataru Hojo
    Ayano Matsumura
    Koji Tsukamoto
    Shinichi Esaki
    Shinichi Iwasaki
    Scientific Reports, 12
  • [25] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Matoba, Takuma
    Minohara, Kiyoshi
    Kawakita, Daisuke
    Takano, Gaku
    Oguri, Keisuke
    Murashima, Akihiro
    Nakai, Kazuyuki
    Iwaki, Sho
    Tsuge, Hiroshi
    Tanaka, Nobukazu
    Imaizumi, Sae
    Hojo, Wataru
    Matsumura, Ayano
    Tsukamoto, Koji
    Esaki, Shinichi
    Iwasaki, Shinichi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [26] Risk of developing hypothyroidism with the use of tyrosine kinase inhibitors and immune checkpoint inhibitors
    Lee, Seung Eun
    Kim, Kyoung-Ah
    Lee, Hyunjung
    Park, Jinkyeong
    CANCER EPIDEMIOLOGY, 2022, 81
  • [27] Immune checkpoint inhibitors may increase risk of AKI
    Reactions Weekly, 2023, 1985 (1) : 11 - 11
  • [28] Immune checkpoint inhibitors increase risk of neurological disorders
    Reactions Weekly, 2021, 1838 (1) : 6 - 6
  • [29] Immune checkpoint inhibitors increase risk of cardiac events
    Reactions Weekly, 2021, 1837 (1) : 11 - 11
  • [30] Suicide risk among cancer survivors: Head and neck versus other cancers
    Osazuwa-Peters, Nosayaba
    Simpson, Matthew C.
    Zhao, Longwen
    Boakye, Eric Adjei
    Olomukoro, Stephanie I.
    Deshields, Teresa
    Loux, Travis M.
    Varvares, Mark A.
    Schootman, Mario
    CANCER, 2018, 124 (20) : 4072 - 4079
12345